MYGN Ticking Higher On Court Ruling
December 17, 2010 at 12:16 PM EST
Shares of Molecular diagnostic products maker Myriad Genetics (MYGN) are surging higher during Friday’s midday trading session. Bloomberg in a recent report said that a court ruled diagnostic tests can be patented. Technically speaking, over the last six month, Myriad has gained nearly 54%, but still remains at depressed levels, having fallen more than 5% [...]
